Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)

Camp4 Therapeutics (CAMP) posted Other Accumulated Expenses of $27000.0 for Q4 2025, down 84.66% sequentially from $176000.0 in Q4 2024, and down 84.66% YoY from $176000.0 in Q4 2024.

Analysis

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

Camp4 Therapeutics has reported Other Accumulated Expenses for 3 years, with the latest figure at $27000.0 in Q4 2025.

  • Quarterly Other Accumulated Expenses fell 84.66% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27000.0 (down 84.66% YoY) and the FY2025 annual result came in at $27000.0, down 84.66% from the prior year.
  • Other Accumulated Expenses fell to $27000.0 in Q4 2025 per CAMP's latest filing, from $176000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $369000.0 in Q3 2024 and troughed at $27000.0 in Q4 2025.
  • A 3-year average of $215250.0 and a median of $232500.0 in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 39.1% in 2024, then sank 84.66% in 2025.
  • Over 3 years, Other Accumulated Expenses stood at $289000.0 in 2023, then slumped by 39.1% to $176000.0 in 2024, then tumbled by 84.66% to $27000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $27000.0, $176000.0, and $369000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 27,000.00
Dec 31, 2024 176,000.00
Sep 30, 2024 369,000.00
Dec 31, 2023 289,000.00